Drugs / AVIDIN PERIODATE OXIDIZED
AVIDIN PERIODATE OXIDIZED
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03188328 | Aug 2017 → Jun 2019 | — | Alfasigma S.p.A. | Terminated | No outcome recorded Stop: Enrollment |
| Phase 1 | NCT02053324 | Nov 2013 → Jun 2019 | metastasis from malignant tumor of colon | Alfasigma S.p.A. | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AVIDIN PERIODATE OXIDIZED | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297898 ↗ |
| Known as | AvidinOX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02053324 ↗ |
| Known as | Periodate oxidized avidin | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297898 ↗ |
| Modality | Protein / enzyme biologic | “AvidinOX is a new compound, essentially a natural protein obtained from hen eggs” NCT02053324 ↗ |
| Route | Other | “One intralesion injection of AvidinOX” NCT02053324 ↗ |